☆ 4.6 Article

Low-dose Esketamine suppresses NLRP3-mediated apoptotic and pyroptotic cell death in microglial cells to ameliorate LPS-induced depression via ablating GSK-3β

BEHAVIOURAL BRAIN RESEARCH (2024)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Clinical Neurology

Effects of different doses of esketamine intervention on postpartum depressive symptoms in cesarean section women: A randomized, double-blind, controlled clinical study

Si Qi Yang et al.

Summary: This study investigated the effect of different doses of esketamine on postpartum depressive symptoms (PDS) in women undergoing cesarean section. The results showed that esketamine can effectively reduce the incidence of PDS and alleviate postoperative pain. Therefore, using esketamine in cesarean section is a safe and low side-effect treatment for PDS.

JOURNAL OF AFFECTIVE DISORDERS (2023)

添加到收藏夹

Article Immunology

Microglial glutaminase 1 deficiency mitigates neuroinflammation associated depression

Chenhui Ji et al.

Summary: Glutaminase 1 (GLS1) has been found to play a crucial role in neuroinflammation, particularly in depression. By targeting GLS1 in microglia, it is possible to alleviate neuroinflammation and depression-like behaviors.

BRAIN BEHAVIOR AND IMMUNITY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses

Tacio de Mendonca Lima et al.

Summary: Ketamine and esketamine have shown significant antidepressant effects within hours or days after administration, but long-term efficacy and the methodological quality of reviews are lacking.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

GSK-3β inhibition protects human nucleus pulposus cell against oxidative stress-inducing apoptosis through mitochondrial pathway

Kai Zhu et al.

Summary: This study found that the GSK-3 beta inhibitor has a protective effect on NP cells against apoptosis under oxidative stress, mainly through protecting the mitochondrial membrane potential, inhibiting the expression of apoptosis-related proteins, and ultimately reducing cell apoptosis.

MOLECULAR BIOLOGY REPORTS (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

GSK-3β-mediated activation of NLRP3 inflammasome leads to pyroptosis and apoptosis of rat cardiomyocytes and fibroblasts

Shu-Hui Wang et al.

Summary: This study demonstrates that GSK-3 beta mediates the activation of the NLRP3 inflammasome/caspase-1/IL-1 beta pathway, leading to apoptosis and pyroptosis in cardiomyocytes and cardiac fibroblasts.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

添加到收藏夹

Article Immunology

Asperosaponin VI ameliorates the CMS-induced depressive-like behaviors by inducing a neuroprotective microglial phenotype in hippocampus via PPAR-γ pathway

Xue Jiang et al.

Summary: The natural compound asperosaponin VI has shown potential as an antidepressant by inducing a neuroprotective phenotype in microglia, potentially through its interaction with PPAR-gamma signaling. This study explored the effects of asperosaponin VI on mice exposed to chronic mild stress (CMS) and found that it ameliorated depression-like behaviors by switching hippocampal microglia from a pro-inflammatory to a neuroprotective phenotype. In addition, asperosaponin VI promoted interactions between microglia and neurons, preserved synaptic function, and regulated cytokine levels in the hippocampus, all of which were dependent on PPAR-gamma signaling. The findings suggest that targeting microglial phenotypes and PPAR-gamma signaling may be a potential strategy for treating depression.

JOURNAL OF NEUROINFLAMMATION (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications

Alexandria N. Tartt et al.

Summary: This review takes a top-down approach to assess how changes in behavior and hippocampal-dependent circuits may be attributed to abnormalities at the molecular, structural, and synaptic level. The discussion focuses on the common effect of antidepressant treatments in modulating neuroplasticity and considers outstanding questions and future perspectives.

MOLECULAR PSYCHIATRY (2022)

添加到收藏夹

Review Psychiatry

Association Between Physical Activity and Risk of Depression A Systematic Review and Meta-analysis

Matthew Pearce et al.

Summary: This systematic review and meta-analysis examines the association between physical activity and depression, and finds significant mental health benefits from being physically active, even at levels below the public health recommendations.

JAMA PSYCHIATRY (2022)

添加到收藏夹

Review Immunology

Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression

Haixia Wang et al.

Summary: This review highlights the role of microglia in the pathology of major depressive disorder. It discusses microglial activation in animal models and clinically depressed patients, as well as the mechanisms by which microglia recognize depression-associated stress and regulate conditions. The review also describes the effects of antidepressants on microglial activation.

JOURNAL OF NEUROINFLAMMATION (2022)

添加到收藏夹

Article Medicine, General & Internal

Effect of Intraoperative Esketamine Infusion on Postoperative Sleep Disturbance After Gynecological Laparoscopy A Randomized Clinical Trial

Di Qiu et al.

Summary: The study demonstrated that intraoperative esketamine infusion can significantly reduce the incidence of postoperative sleep disturbance in patients undergoing gynecological laparoscopic surgery.

JAMA NETWORK OPEN (2022)

添加到收藏夹

Article Neurosciences

Esketamine alleviates postoperative cognitive decline via stimulator of interferon genes/TANK-binding kinase 1 signaling pathway in aged rats

Yan Li et al.

Summary: This study found that esketamine can alleviate surgery-induced POCD in rats through inhibition of the STING/TBK1 signaling pathway.

BRAIN RESEARCH BULLETIN (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review

Dominika Psiuk et al.

Summary: This publication discusses the use of psilocybin and esketamine, which belong to the psychoactive substances group, in the treatment of depression. Recent studies have shown that these substances have the potential to be novel antidepressant agents. Both psilocybin and esketamine have been found to rapidly and long-term reduce depressive symptoms.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Cell Biology

Microglial NLRP3 inflammasome activates neurotoxic in-like mice

Shanshan Li et al.

Summary: This study reveals the involvement of neurotoxic reactive astrocytes and microglial NLRP3 inflammasome in depression. Knockout of Nlrp3 in microglial cells alleviates the induction of A1-like astrocytes and improves neuronal dysfunction. The NF-KB pathway and caspase-1 activation play crucial roles in the production of A1-like astrocytes.

CELL REPORTS (2022)

添加到收藏夹

Article Neurosciences

Albumin alleviated esketamine-induced neuronal apoptosis of rat retina through downregulation of Zn2+-dependent matrix metalloproteinase 9 during the early development

Kan Zhang et al.

Summary: Albumin can alleviate esketamine-induced neuronal apoptosis by reducing the accumulation of Zn2+ and downregulating Zn2+-dependent MMP9. It also protects neurons by decreasing inflammation.

BMC NEUROSCIENCE (2022)

添加到收藏夹

Article Neurosciences

Esketamine improves propofol-induced brain injury and cognitive impairment in rats

Guiping Xu et al.

Summary: Propofol, an intravenous anesthetic, induces neurotoxicity, but esketamine can attenuate propofol-induced brain injury and cognitive dysfunction by activating the mBDNF/TrkB/PI3K signaling pathway.

TRANSLATIONAL NEUROSCIENCE (2022)

添加到收藏夹

Article Cell Biology

Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy

Qisheng Lin et al.

Summary: This study elucidated a novel mechanism in which NLRP3 inflammasome inhibition attenuated apoptosis and upregulated HIF1A and BNIP3-mediated mitophagy in CI-AKI, indicating the potential applications of MCC950 and roxadustat in clinical CI-AKI treatment.

AUTOPHAGY (2021)

添加到收藏夹

Article Behavioral Sciences

Saikosaponin A improved depression -like behavior and inhibited hippocampal neuronal apoptosis after cerebral ischemia through p-CREB/BDNF pathway

An-rong Wang et al.

Summary: This study demonstrated that Saikosaponin A can significantly alleviate depressive-like behavior in rats after cerebral ischemia, by regulating the expression of BDNF, p-CREB, and Bcl-2, lowering levels of Bax and Caspase-3, and inhibiting neuronal apoptosis in the hippocampus. Therefore, Saikosaponin A may improve depressive symptoms and inhibit neuronal apoptosis by modulating the expression of these molecules.

BEHAVIOURAL BRAIN RESEARCH (2021)

添加到收藏夹

Article Immunology

Neuroinflammation induces anxiety- and depressive-like behavior by modulating neuronal plasticity in the basolateral amygdala

Zhi-Heng Zheng et al.

Summary: Excessive inflammatory responses are linked to psychiatric diseases, affecting neural plasticity in the amygdala and leading to anxiety and depression symptoms.

BRAIN BEHAVIOR AND IMMUNITY (2021)

添加到收藏夹

Article Immunology

Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a/SYK/NF-κB axis

Yuanjie Li et al.

Summary: The results showed that miRNA-27a expression was reduced in the serum of depressed patients and in animal models of depression. Isoliquiritin demonstrated significant antidepressant effects by decreasing NLRP3-mediated pyroptosis through the miRNA-27a/SYK/NF-kappa B axis.

JOURNAL OF NEUROINFLAMMATION (2021)

添加到收藏夹

Article Immunology

Ibrutinib alleviates LPS-induced neuroinflammation and synaptic defects in a mouse model of depression

Weifen Li et al.

Summary: The study demonstrated that ibrutinib has potential anti-depressive effects by reducing neuroinflammation and synaptic defects in a mouse model of LPS-induced depression. Ibrutinib treatment inhibited NF-kB activation and proinflammatory cytokine levels, and improved synaptic markers in the hippocampus, suggesting its antidepressant potential against inflammation-induced depression.

BRAIN BEHAVIOR AND IMMUNITY (2021)

添加到收藏夹

Article Neurosciences

TRPV4 inhibitor HC067047 produces antidepressant-like effect in LPS-induced depression mouse model

Wei Li et al.

Summary: It has been found that TRPV4 plays a significant role in LPS-induced depression by regulating inflammatory responses in the hippocampus, which affects depressive behaviors. The study suggests that TRPV4 may be a potential target for treating depression associated with inflammation.

NEUROPHARMACOLOGY (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

In the Clinic Depression

Robert M. McCarron et al.

ANNALS OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Medicine, Research & Experimental

NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression

Shanshan Li et al.

Summary: The study revealed the presence of astrocytic pyroptosis in depressive mice, which could be mitigated with treatment. Genetic knockout and overexpression experiments on mice also provided insights into the involvement of specific proteins in depression-related astrocyte loss.

JCI INSIGHT (2021)

添加到收藏夹

Article Psychiatry

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study

Sanne Y. Smith-Apeldoorn et al.

Summary: Oral esketamine treatment for patients with chronic and severe treatment-resistant depression is safe and well-tolerated, but has modest therapeutic effects, with only partial response observed in some participants.

BJPSYCH OPEN (2021)

添加到收藏夹

Article Clinical Neurology

PSD-93 up-regulates the synaptic activity of corticotropin-releasing hormone neurons in the paraventricular nucleus in depression

Xin-Ya Qin et al.

Summary: The study observed an increased density of PSD-93-CRH co-localized neurons in the hypothalamic PVN of major depression patients, showing that PSD-93 regulates excitatory synaptic activity in CRH neurons leading to depression-like behaviors. PSD-93 overexpression heightened HPA axis activity, while PSD-93 knockdown alleviated depression phenotypes.

ACTA NEUROPATHOLOGICA (2021)

添加到收藏夹

Article Clinical Neurology

Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders

Felicia Ceban et al.

Summary: The emerging roles of ketamine and esketamine as effective rapid-acting antidepressants offer hope for patients with treatment-resistant depression, but practitioners need to be familiar with common adverse events and strategies for prevention and management to reduce patient burden.

CNS DRUGS (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Hesperetin ameliorates diabetes-associated anxiety and depression-like behaviors in rats via activating Nrf2/ARE pathway

Xia Zhu et al.

Summary: This study demonstrates that hesperetin has anxiolytic and antidepressant effects in diabetic rats, potentially through activation of the Nrf2/ARE pathway. Furthermore, activation of Nrf2/ARE pathway by hesperetin is facilitated by increased nuclear Nrf2 phosphorylation through PKC activation and GSK-3 beta inhibition.

METABOLIC BRAIN DISEASE (2021)

添加到收藏夹

Article Neurosciences

Early-life inflammation promotes depressive symptoms in adolescence via microglial engulfment of dendritic spines

Peng Cao et al.

Summary: Early-life inflammation can increase the risk for depression in later life by affecting the long-term neuronal spine engulfment capacity of microglia. Mouse studies have shown that depressive-like stress can increase microglial engulfment of specific neuronal spines, and inhibiting microglial activity may reduce depressive symptoms.

NEURON (2021)

添加到收藏夹

Review Clinical Neurology

Ketamine: A tale of two enantiomers

Luke A. Jelen et al.

Summary: The discovery of ketamine's rapid antidepressant effects has been a significant breakthrough in depression research, although its use is limited by dissociative effects and abuse potential. Research on (R)-ketamine suggests it may have stronger and longer lasting antidepressant effects with fewer side effects compared to (S)-ketamine, and ongoing studies aim to understand the underlying mechanisms for future antidepressant drug development.

JOURNAL OF PSYCHOPHARMACOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Cisplatin Induces Pyroptosis via Activation of MEG3/NLRP3/caspase-1/GSDMD Pathway in Triple-Negative Breast Cancer

Honglin Yan et al.

Summary: The study revealed that cisplatin induces pyroptosis in triple-negative breast cancer cells through activation of the MEG3/NLRP3/caspase-1/GSDMD pathway, leading to its anti-tumor effects. This finding may contribute to the development of new therapeutic strategies for TNBC.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

EPA is More Effective than DHA to Improve Depression-Like Behavior, Glia Cell Dysfunction and Hippcampal Apoptosis Signaling in a Chronic Stress-Induced Rat Model of Depression

Zhilan Peng et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Review Neurosciences

Adiponectin peptide alleviates oxidative stress and NLRP3 inflammasome activation after cerebral ischemia-reperfusion injury by regulating AMPK/GSK-3β

Haixiao Liu et al.

EXPERIMENTAL NEUROLOGY (2020)

添加到收藏夹

Review Immunology

The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis)

Min Zheng et al.

IMMUNOLOGICAL REVIEWS (2020)

添加到收藏夹

Article Immunology

A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment

He-Yang Zhang et al.

JOURNAL OF NEUROINFLAMMATION (2020)

添加到收藏夹

Review Neurosciences

The Bidirectional Relationship of Depression and Inflammation: Double Trouble

Eleonore Beurel et al.

NEURON (2020)

添加到收藏夹

Article Cell Biology

Suppressing the Na+/H+ exchanger 1: a new sight to treat depression

Xueyang Deng et al.

CELL DEATH & DISEASE (2019)

添加到收藏夹

Review Clinical Neurology

Esketamine for treatment resistant depression

Jennifer Swainson et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)

添加到收藏夹

Article Cell Biology

Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome

Lingbin Sun et al.

CELL DEATH & DISEASE (2019)

添加到收藏夹

Article Psychiatry

Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression A Randomized Clinical Trial

Ella J. Daly et al.

JAMA PSYCHIATRY (2019)

添加到收藏夹

Article Immunology

Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway

Burak Arioz et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Review Neurosciences

The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature

J. F. Costemale-Lacoste et al.

ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3β/caspase-3 mediated signaling pathway

Yan Wu et al.

APOPTOSIS (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.